Archives
Please, enter cell line, author or any other phrase or word you would like to search for.
PHI, SAS, QIAGEN and BioSpherix form Alliance to Advance Cell-based Biomanufacturing
In association with the Wake Forest Institute for Regenerative Medicine, PHI, BioSpherix, analytics leader SAS and QIAGEN have created a technology development alliance to create the AI-based process control tools needed for automated biomanufacturing.
BioStock: PHI expands market potential with regenerative medicine opportunity
BioStock contacted CFO Patrik Eschricht to find out more about PHI’s visions regarding regenerative medicine, cell-based therapies and automatization of biomanufacturing.
Interim Report 1 2022/23
Despite a summer-sluggish period ending in July, sales were just one unit away from surpassing our best quarter ever; the same period last year.
Wake Forest Institute for Regenerative Medicine Welcomes PHI
PHI visits the WFIRM to finalize an agreement concerning the automation of advanced quality control in large-scale biomanufacturing of regenerative therapies.
HoloMonitor user Spotlight: Tianyan Wang
Tianyan talks about how digital holographic cytometry (DHC) and HoloMonitor data have been key in his Ph.D. thesis: Utility of Novel Drug Targets for Treatment of Metastatic Cancer.
Webinars in Chinese! – Everything you need to know about HoloMonitor
To help our customers who speak different languages, PHI and our local partner in China, Bio-Sun, held two webinars in Chinese to explain everything you need to know about HoloMonitor.
HoloMonitor User Spotlight: Francesco Pasqualini
Francesco Pasqualini, Associate Professor at University Pavia, tells how he applies HoloMonitor to see how ECM affects cells over a long time.
Year-end Report 2021/22
Sales more than doubled in 2021/22, compared to previous financial year.
Synthetic antibody patent awarded to PHI by Japan
PHI announces today that the Company has been granted a patent concerning synthetic antibodies in Japan.
HoloMonitor user spotlight: Robert Judson-Torres
To be a mole or to be a melanoma? Dr. Robert Judson-Torres, Assistant Professor at Huntsman Cancer Institute, University of Utah, speaks about how HoloMonitor data has been key in his recent work.